Five Prime Therapeutics (FPRX) Sees Windfall on Anti-CSF1R Collaboration Agreement (BMY)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 62.42 -0.06 (0.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.48 | 52 Week High | $77.12 | |||
| Open | $62.45 | 52 Week Low | $49.03 | |||
| Day High | $62.74 | P/E | 40.53 | |||
| Day Low | $62.17 | EPS | $1.54 | |||
| Volume | 1,372,484 | |||||
| FIVE PRIME THER (NASDAQ: FPRX) | Delayed: 38.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.00 | 52 Week High | $57.79 | |||
| Open | $43.46 | 52 Week Low | $28.01 | |||
| Day High | $38.00 | P/E | N/A | |||
| Day Low | $38.00 | EPS | $-2.50 | |||
| Volume | 329,789 | |||||
